Seizure News and Research

Latest Seizure News and Research

Anti-epileptic drugs, bone loss and supplements

Anti-epileptic drugs, bone loss and supplements

UT Arlington assistant professor develops computational model to predict epileptic seizure

UT Arlington assistant professor develops computational model to predict epileptic seizure

Cedars-Sinai study presents new insights into mechanisms underlying the symptoms of autism

Cedars-Sinai study presents new insights into mechanisms underlying the symptoms of autism

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Vaccinating kids against rotavirus may also reduce risk of seizures

Vaccinating kids against rotavirus may also reduce risk of seizures

Watertree Health, Make-A-Wish Arizona partner to support children with life-threatening conditions

Watertree Health, Make-A-Wish Arizona partner to support children with life-threatening conditions

Basic first aid tips for people with epilepsy

Basic first aid tips for people with epilepsy

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

NeuroPace RNS System gets premarket approval from FDA for treatment of partial onset seizures

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

Medical device to reduce frequency of seizures in epilepsy patients gets FDA approval

Experts gather for first national conference focusing on the treatment of non-epileptic seizures

Experts gather for first national conference focusing on the treatment of non-epileptic seizures

Aptiom receives FDA approval to treat seizures associated with epilepsy

Aptiom receives FDA approval to treat seizures associated with epilepsy

Risedronate may help prevent new vertebral fractures when taken with calcium and vitamin D

Risedronate may help prevent new vertebral fractures when taken with calcium and vitamin D

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

UTHealth researchers investigate clot-buster for children with acute ischemic stroke

UTHealth researchers investigate clot-buster for children with acute ischemic stroke

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

Researchers receive grant to accelerate development of mobile seizure alert system for epilepsy patients

Researchers receive grant to accelerate development of mobile seizure alert system for epilepsy patients

Discovery of neural firing-rate set point opens door to possible treatment for devastating disorders

Discovery of neural firing-rate set point opens door to possible treatment for devastating disorders

Measles-containing vaccines administered at 12-5 months of age associated with reduced risk of fever, seizures

Measles-containing vaccines administered at 12-5 months of age associated with reduced risk of fever, seizures

Team Ritter to raise funds for John Ritter Foundation for Aortic Health at ING NYC Marathon

Team Ritter to raise funds for John Ritter Foundation for Aortic Health at ING NYC Marathon

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.